Viewing Study NCT01148459


Ignite Creation Date: 2025-12-24 @ 2:54 PM
Ignite Modification Date: 2026-05-18 @ 5:06 AM
Study NCT ID: NCT01148459
Status: COMPLETED
Last Update Posted: 2019-01-16
First Post: 2010-06-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malaria View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Plasmodium falciparum View
None schedule View
None HIV View
None malaria vaccine View
None EPI View
None Africa View